These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Correction of a urea cycle defect after ex vivo gene editing of human hepatocytes. Zabulica M, Srinivasan RC, Akcakaya P, Allegri G, Bestas B, Firth M, Hammarstedt C, Jakobsson T, Jakobsson T, Ellis E, Jorns C, Makris G, Scherer T, Rimann N, van Zuydam NR, Gramignoli R, Forslöw A, Engberg S, Maresca M, Rooyackers O, Thöny B, Häberle J, Rosen B, Strom SC. Mol Ther; 2021 May 05; 29(5):1903-1917. PubMed ID: 33484963 [Abstract] [Full Text] [Related]
4. Preclinical evaluation of a clinical candidate AAV8 vector for ornithine transcarbamylase (OTC) deficiency reveals functional enzyme from each persisting vector genome. Wang L, Morizono H, Lin J, Bell P, Jones D, McMenamin D, Yu H, Batshaw ML, Wilson JM. Mol Genet Metab; 2012 Feb 05; 105(2):203-11. PubMed ID: 22133298 [Abstract] [Full Text] [Related]
5. Variant analysis and PGT-M of OTC gene in a Chinese family with ornithine carbamoyltransferase deficiency. Zhou Y, Jiang X, Zhang Y, Zhang Y, Sun F, Ma Y. BMC Pregnancy Childbirth; 2024 Jul 22; 24(1):491. PubMed ID: 39039447 [Abstract] [Full Text] [Related]
8. Recapitulation of Skewed X-Inactivation in Female Ornithine Transcarbamylase-Deficient Primary Human Hepatocytes in the FRG Mouse: A Novel System for Developing Epigenetic Therapies. Cunningham SC, van Dijk EB, Zhu E, Sugden M, Mandwie M, Siew S, Devanapalli B, Tolun AA, Klein A, Wilson L, Aryamanesh N, Gissen P, Baruteau J, Bhattacharya K, Alexander IE. Hum Gene Ther; 2023 Sep 22; 34(17-18):917-926. PubMed ID: 37350098 [Abstract] [Full Text] [Related]